8R0G

Capsid structure of Giardiavirus (GLV) CAT strain

PDB DOI: https://doi.org/10.2210/pdb8R0G/pdb
EM Map EMD-18792: EMDB EMDataResource

Classification: VIRUS
Organism(s): Giardia lamblia virus
Mutation(s): No

Deposited: 2023-10-31 Released: 2024-04-03
Deposition Author(s): Wang, H., Gianluca, M., Munke, A., Hassan, M.M., Lalle, M., Okamoto, K.
Funding Organization(s): Swedish Research Council, Norwegian Research Council

Experimental Data Snapshot

Method: ELECTRON MICROSCOPY
Resolution: 2.60 Å
Aggregation State: PARTICLE
Reconstruction Method: SINGLE PARTICLE

wwPDB Validation 3D Report Full Report

This is version 1.0 of the entry. See complete history.

Literature

Capsid structure of Giardiavirus (GLV) CAT strain

Wang, H., Gianluca, M., Munke, A., Hassan, M.M., Lalle, M., Okamoto, K.

To be published.

Macromolecule Content

Total Structure Weight: 206.98 kDa
Atom Count: 13,445
Modelled Residue Count: 1,708
Deposited Residue Count: 1,858
Unique protein chains: 1

Macromolecules

Find similar proteins by:

(by identity cutoff) | 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Capsid protein	A, B	929	Giardia lamblia virus	Mutation(s): 0
UniProt
Find proteins for A0A8F6AGH5 (Giardiavirus sp) Explore A0A8F6AGH5 Go to UniProtKB: A0A8F6AGH5
Entity Groups
Sequence Clusters	30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt Group	A0A8F6AGH5
Sequence Annotations Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

Method: ELECTRON MICROSCOPY
Resolution: 2.60 Å
Aggregation State: PARTICLE
Reconstruction Method: SINGLE PARTICLE

Structure Validation

View Full Validation Report

Entry History & Funding Information

Deposition Data

Released Date: 2024-04-03

Deposition Author(s):

Funding Organization	Location	Grant Number
Swedish Research Council	Sweden	2018-03387
Swedish Research Council	Sweden	2018-00421
Norwegian Research Council	Norway	324266

Revision History (Full details and data files)

Version 1.0: 2024-04-03
Type: Initial release

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.